Supplementary Figure 8 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer | Synapse
October 7, 2024Open Access
Supplementary Figure 8 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Supplemental Figure 8 shows the relationship between the Fraction of Genome Altered by UROMOL subgroups within the MSK cohort.